[Our experience with complex drug therapy of diabetic retinopathy].
D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D064987:Cell- and Tissue-Based Therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D008049:Lipase / Q000627:therapeutic use; D008696:Methandrostenolone / Q000627:therapeutic use; D008715:Methionine / Q000627:therapeutic use; D008875:Middle Aged; D013835:Thiamine Pyrophosphate / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
D014815:Vitamins; D000255:Adenosine Triphosphate; D006493:Heparin; D008012:Lidocaine; D008715:Methionine; D008696:Methandrostenolone; D008049:Lipase; D013835:Thiamine Pyrophosphate
Nash opyt kompleksnoĭ medikamentoznoĭ terapii diabeticheskoĭ retinopatii